Linjuan Zeng

1.6k total citations
44 papers, 1.2k citations indexed

About

Linjuan Zeng is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Linjuan Zeng has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Linjuan Zeng's work include Pancreatic and Hepatic Oncology Research (13 papers), MicroRNA in disease regulation (8 papers) and RNA Interference and Gene Delivery (7 papers). Linjuan Zeng is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), MicroRNA in disease regulation (8 papers) and RNA Interference and Gene Delivery (7 papers). Linjuan Zeng collaborates with scholars based in China, United States and South Sudan. Linjuan Zeng's co-authors include Kaihong Huang, Yinting Chen, Guoda Lian, Chenchen Qian, Shaojie Chen, Qiubo Zhang, Yaqing Li, Chumei Huang, Kege Yang and Jiajia Li and has published in prestigious journals such as Biomaterials, Oncogene and Nanoscale.

In The Last Decade

Linjuan Zeng

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linjuan Zeng China 21 583 522 352 180 141 44 1.2k
Wantong Yao China 21 770 1.3× 540 1.0× 382 1.1× 171 0.9× 148 1.0× 29 1.5k
Kaihong Huang China 24 752 1.3× 643 1.2× 411 1.2× 188 1.0× 188 1.3× 64 1.5k
Claire Viallard France 9 798 1.4× 355 0.7× 452 1.3× 208 1.2× 73 0.5× 10 1.4k
Quan-Xing Ni China 18 462 0.8× 638 1.2× 282 0.8× 98 0.5× 122 0.9× 25 1.3k
Yanmin Xu China 18 1.1k 1.8× 507 1.0× 566 1.6× 135 0.8× 90 0.6× 24 1.6k
Dongjun Jeong South Korea 21 798 1.4× 528 1.0× 294 0.8× 202 1.1× 84 0.6× 55 1.6k
Christina Körbel Germany 19 630 1.1× 264 0.5× 234 0.7× 154 0.9× 70 0.5× 39 1.3k
Jennifer A. Roth United States 14 662 1.1× 406 0.8× 222 0.6× 112 0.6× 61 0.4× 47 1.2k
Crina Tiron Romania 12 552 0.9× 540 1.0× 186 0.5× 407 2.3× 81 0.6× 27 1.3k
Jianting Long China 20 784 1.3× 290 0.6× 512 1.5× 81 0.5× 99 0.7× 51 1.2k

Countries citing papers authored by Linjuan Zeng

Since Specialization
Citations

This map shows the geographic impact of Linjuan Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linjuan Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linjuan Zeng more than expected).

Fields of papers citing papers by Linjuan Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linjuan Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linjuan Zeng. The network helps show where Linjuan Zeng may publish in the future.

Co-authorship network of co-authors of Linjuan Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Linjuan Zeng. A scholar is included among the top collaborators of Linjuan Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linjuan Zeng. Linjuan Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhuang, Weitao, Dongfang Wu, Lanlan Pang, et al.. (2024). EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47. Journal of Thoracic Oncology. 19(8). 1186–1200. 23 indexed citations
3.
Zhang, Weiyu, et al.. (2024). GDNF-induced phosphorylation of MUC21 promotes pancreatic cancer perineural invasion and metastasis by activating RAC2 GTPase. Oncogene. 43(34). 2564–2577. 10 indexed citations
4.
5.
6.
Liu, Kecheng, et al.. (2023). Upregulation of Apolipoprotein L6 Improves Tumor Immunotherapy by Inducing Immunogenic Cell Death. Biomolecules. 13(3). 415–415. 8 indexed citations
7.
8.
Peng, Siqi, Yujing Lin, Chumei Huang, et al.. (2019). MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer. International Journal of Oncology. 55(1). 142–156. 36 indexed citations
9.
Huang, Chumei, Yaqing Li, Yubo Guo, et al.. (2018). MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells. Theranostics. 8(11). 3074–3086. 75 indexed citations
10.
Zeng, Linjuan, Yong Wang, William H. Tolleson, et al.. (2017). The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p. Biochemical Pharmacology. 145. 178–191. 40 indexed citations
11.
Li, Yaqing, Yinting Chen, Jiajia Li, et al.. (2017). Co‐delivery of micro RNA ‐21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy. Cancer Science. 108(7). 1493–1503. 107 indexed citations
12.
Zeng, Linjuan, Yong Wang, Li‐Rong Yu, et al.. (2017). MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation. Biochemical Pharmacology. 140. 139–149. 51 indexed citations
13.
Zhang, Qiubo, Linjuan Zeng, Yinting Chen, et al.. (2016). New developments in the early diagnosis of pancreatic cancer. Expert Review of Gastroenterology & Hepatology. 11(2). 149–156. 21 indexed citations
14.
Chen, Shaojie, Yinting Chen, Linjuan Zeng, et al.. (2016). Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro. Tumor Biology. 37(8). 11299–11309. 5 indexed citations
15.
Chen, Yinting, Yanzhu Chen, Shaojie Chen, et al.. (2015). Primary Gastrointestinal Lymphoma. Medicine. 94(47). e2119–e2119. 20 indexed citations
16.
17.
Peng, Peijian, Hua Cheng, Linjuan Zeng, et al.. (2014). Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis. Drug Design Development and Therapy. 8. 1083–1083. 12 indexed citations
18.
Qian, Chenchen, Yong Wang, Yinting Chen, et al.. (2013). Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles. Biomaterials. 34(26). 6175–6184. 58 indexed citations
19.
20.
Huang, Kaihong, Yinting Chen, Weiwei Wang, et al.. (2012). Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer. International Journal of Nanomedicine. 7. 359–359. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wantong Yao Breakdown of academic impact, for papers by Kaihong Huang Breakdown of academic impact, for papers by Claire Viallard Breakdown of academic impact, for papers by Quan-Xing Ni Breakdown of academic impact, for papers by Yanmin Xu Breakdown of academic impact, for papers by Dongjun Jeong Breakdown of academic impact, for papers by Christina Körbel Breakdown of academic impact, for papers by Jennifer A. Roth Breakdown of academic impact, for papers by Crina Tiron Breakdown of academic impact, for papers by Jianting Long
Rankless by CCL
2026